AI Market Mood: Stock Dashboard
IMNM
Fundamental
Company: Immunome Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -2.96
Insider Own: 8.33%
Shs Outstand: 91.71M
Perf Week: 8.11%
Market Cap: 1.70B
Forward P/E: -
EPS next Y: -2.50
Insider Trans: 0.07%
Shs Float: 84.07M
Perf Month: 15.38%
Enterprise Value: 1.43B
PEG: -
EPS next Q: -0.57
Inst Own: 96.18%
Short Float: 17.95%
Perf Quarter: 86.79%
Income: -222.74M
P/S: 175.56
EPS this Y: 56.02%
Inst Trans: 6.11%
Short Ratio: 10.36
Perf Half Y: 118.26%
Sales: 9.68M
P/B: 6.44
EPS next Y Percentage: -13.72%
ROA: -80.08%
Short Interest: 15.09M
Perf YTD: 74.48%
Book/sh: 2.88
P/C: 6.23
EPS next 5Y: 23.42%
ROE: -93.04%
52W High: 18.94 -2.18%
Perf Year: 97.34%
Cash/sh: 2.97
P/FCF: -
EPS past 3/5Y: -32.63% -38.15%
ROIC: -83.13%
52W Low: 5.15 259.80%
Perf 3Y: 365.58%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: 71.34%
Volatility W: 7.12%
Volatility M: 7.55%
Perf 5Y: 61.69%
Dividend TTM: -
EV/Sales: 147.81
EPS Y/Y TTM: 63.58%
Oper. Margin: -2137.10%
ATR (14): 1.25
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 8.90
Sales Y/Y TTM: -4.44%
Profit Margin: -2301.30%
RSI (14): 64.89
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 8.90
EPS Q/Q: 16.50%
SMA20: 10.94%
Beta: 2.12
Target Price: 24.23
Payout: -
Debt/Eq: 0.02
Sales Q/Q: -100.00%
SMA50: 28.62%
Rel Volume: 0.98
Prev Close: 17.51
Employees: 118
LT Debt/Eq: 0.02
Earnings: Nov 06 AMC
SMA200: 79.17%
Avg Volume: 1.46M
Price: 18.53
IPO: Oct 02, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: -14.94% -100.00%
Trades:
Volume: 1,430,194
Change: 5.83%
Technical:
Latest News:
Immunome to Present at 2024 Bank of America Healthcare Conference | Business Wire neutral
IMNM
Summary: Immunome, Inc. announced that its President and CEO will present at the Bank of America Healthcare Conference on May 15, 2024.
Full article2024-05-08T12:01:40Z